Related Experiment Video

Updated: Apr 23, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.6K

A rare case of primary malignant pericardial mesothelioma

Rajoo Ramachandran1, Prabhu Radhan1, Roy Santosham1

  • 1Department of Radiology, Sri Ramachandra University, Chennai, Tamilnadu, India.

Journal of Clinical Imaging Science
|September 25, 2014
PubMed

Insights

Primary malignant pericardial mesothelioma (PMPM) is a rare tumor with a poor prognosis. This study highlights its radiological features and pathological confirmation using new immunohistochemical markers.

Area of Science:

  • Oncology
  • Pathology
  • Radiology

Background:

  • Primary malignant pericardial mesothelioma (PMPM) is an exceptionally rare tumor originating in the pericardium.
  • The etiology of PMPM remains largely unknown, and it is associated with a very poor patient prognosis.
  • While asbestos exposure is a known risk factor for pleural and peritoneal mesothelioma, its role in PMPM is uncertain.

Purpose of the Study:

  • To describe the characteristic radiological findings of primary malignant pericardial mesothelioma.
  • To correlate radiological findings with pathological confirmation.
  • To demonstrate the utility of novel immunohistochemical (IHC) markers in diagnosing PMPM.

Main Methods:

  • Review of radiological imaging features of confirmed PMPM cases.
  • Pathological examination of pericardial tissue.
  • Application of new immunohistochemical (IHC) markers for diagnostic confirmation.

Main Results:

  • Detailed description of the radiological appearance of PMPM.
  • Correlation between imaging findings and histopathological diagnosis.
  • Successful confirmation of PMPM using advanced IHC markers.

Conclusions:

  • Radiological imaging plays a crucial role in the initial detection and characterization of PMPM.
  • Immunohistochemical markers are essential for definitive pathological diagnosis of this rare tumor.
  • Further research is needed to elucidate the etiology and improve the prognosis of PMPM.
Keywords:
Immunohistochemical markerspericardial effusionpericardial mesotheliomapericardial thickening

More Related Videos

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

8.8K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

6.3K

Related Concept Videos

Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
746
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
626
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
809
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
1.1K
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
583
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
793